Description
如眠是一款用于治疗慢性失眠的数字疗法软件，依据失眠的认知行为疗法（CBT-I）研发，以模拟现实中面对面的CBT-I治疗方式来实现治疗。
CBT-I的科学性已经广泛被认可，已被《中国失眠障碍综合防治指南》、美国内科医师协会、欧洲睡眠研究会推荐为治疗慢性失眠的首选方式，能有效并持续改善失眠症状。
本软件适用于18周岁及以上慢性失眠患者的治疗。
CBT-I的科学性已经广泛被认可，已被《中国失眠障碍综合防治指南》、美国内科医师协会、欧洲睡眠研究会推荐为治疗慢性失眠的首选方式，能有效并持续改善失眠症状。
本软件适用于18周岁及以上慢性失眠患者的治疗。
Screenshots
如眠 FAQ
-
Is 如眠 free?
Yes, 如眠 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 如眠 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 如眠 cost?
如眠 is free.
-
What is 如眠 revenue?
To get estimated revenue of 如眠 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Colombia yet.
Ratings History
如眠 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
如眠 Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
速眠医生
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
小懂健康
有小懂就够了
|
Unlock
|
Unlock
|
0
|
|
1 month ago | |
术康医生Pro
|
Unlock
|
Unlock
|
0
|
|
9 months ago | |
伸腰
业界良心为腰颈疼痛朋友打造的康复神器
|
Unlock
|
Unlock
|
0
|
|
1 month ago | |
PULSE治愈-权威冥想课程，情绪跟踪数字疗法平台
循证课程，顶级声优，音乐疗法，解压专注缓解情绪，重塑健康心理
|
Unlock
|
Unlock
|
0
|
|
2 months ago | |
美高CBTI
睡眠数字疗法，高效助眠
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
绵羊睡眠（健康版）
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
医阶
听医学就在医阶
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
心管家
守护您的心脏健康
|
Unlock
|
Unlock
|
0
|
|
2 months ago | |
望里心灵
|
Unlock
|
Unlock
|
0
|
|
8 months ago |
如眠 Installs
Last 30 days
如眠 Revenue
Last 30 days如眠 Revenue and Downloads
Gain valuable insights into 如眠 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
-
Shenzhen Zeen Health Technology Co
- Languages
- English, Chinese
- Recent release
- 1.0.3 (2 years ago )
- Released on
- Oct 12, 2021 (3 years ago )
- Also available in
- China , Poland , Italy , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , Pakistan , Israel , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Dominican Republic , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , Colombia , Czechia , Germany , Denmark , India , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Croatia , Hungary , Indonesia , Ireland , United Arab Emirates
- Last Updated
- 1 month ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.